We are live on ! Find out more
SR

Syntax Research Portfolio holdings

AUM $137M
1-Year Est. Return 21.22%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+21.22%
3 Year Est. Return
+42.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.04M
Cap. Flow
-$11.9M
Cap. Flow %
-8.48%
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$2.35M
2
ZTS icon
Zoetis
ZTS
+$2.21M
3
WTW icon
Willis Towers Watson
WTW
+$2.17M
4
PANW icon
Palo Alto Networks
PANW
+$2.16M
5
ACN icon
Accenture
ACN
+$2.03M

Top Sells

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$3.4M
2
AMT icon
American Tower
AMT
+$3.32M
3
NEM icon
Newmont
NEM
+$3.21M
4
COLD icon
Americold
COLD
+$2.6M
5
MRK icon
Merck
MRK
+$2.39M

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.08%
2 Technology 19.94%
3 Healthcare 5.03%
4 Industrials 4.92%
5 Financials 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHEL icon
151
Shell
SHEL
$256B
$5.84K ﹤0.01%
83
– –
OTIS icon
152
Otis Worldwide
OTIS
$27.1B
$5.84K ﹤0.01%
59
– –
ALL icon
153
Allstate
ALL
$65.6B
$5.64K ﹤0.01%
28
– –
LVS icon
154
Las Vegas Sands
LVS
$28.7B
$5.61K ﹤0.01%
129
– –
HE icon
155
Hawaiian Electric Industries
HE
$1.92B
$5.4K ﹤0.01%
508
– –
VKTX icon
156
Viking Therapeutics
VKTX
$4.07B
$5.3K ﹤0.01%
200
– –
SHYG icon
157
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.7B
$5.26K ﹤0.01%
122
-67
-35% -$2.83K
IGSB icon
158
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$5.22K ﹤0.01%
99
– –
DAL icon
159
Delta Air Lines
DAL
$52.7B
$4.92K ﹤0.01%
100
– –
WMT icon
160
Walmart Inc
WMT
$850B
$4.89K ﹤0.01%
50
– –
LUV icon
161
Southwest Airlines
LUV
$19.4B
$4.48K ﹤0.01%
138
– –
QCLN icon
162
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$564M
$3.27K ﹤0.01%
100
– –
AIA icon
163
iShares Asia 50 ETF
AIA
$5.38B
$2.84K ﹤0.01%
35
– –
MRNA icon
164
Moderna
MRNA
$58.1B
$2.76K ﹤0.01%
100
– –
MSI icon
165
Motorola Solutions
MSI
$77.5B
$2.52K ﹤0.01%
6
– –
DXC icon
166
DXC Technology
DXC
$1.86B
$2.48K ﹤0.01%
162
– –
AAL icon
167
American Airlines Group
AAL
$8.69B
$2.24K ﹤0.01%
200
– –
CCCC icon
168
C4 Therapeutics
CCCC
$463M
$1.43K ﹤0.01%
1,000
– –
QS icon
169
QuantumScape Corp
QS
$3.37B
$1.01K ﹤0.01%
150
– –
LXRX icon
170
Lexicon Pharmaceuticals
LXRX
$997M
$135 ﹤0.01%
142
– –
ITA icon
171
iShares US Aerospace & Defense ETF
ITA
$13.5B
– –
-158
Closed -$26.2K
CLX icon
172
Clorox
CLX
$11.3B
– –
-221
Closed -$32.5K
CME icon
173
CME Group
CME
$101B
– –
-1,857
Closed -$493K
COLD icon
174
Americold
COLD
$4.06B
– –
-121,001
Closed -$2.6M
CUBE icon
175
CubeSmart
CUBE
$8.89B
– –
-416
Closed -$17.8K
4 5 6
7
8

Similar funds

CCM
Crabel Capital Management Los Angeles, California $137M AUM 4.21% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
II
Impact Investors San Francisco, California $137M AUM 20.69% 1-Year Est. Return
SWP
Stone Wealth Partners Lafayette, Louisiana $137M AUM
BCM
Barrier Capital Management San Francisco, California $137M AUM 43.09% 1-Year Est. Return
MWP
Momentum Wealth Planning Estero, Florida $137M AUM 44.08% 1-Year Est. Return
TWM
Timmons Wealth Management Attleboro, Massachusetts $137M AUM
TPCM
Templeton & Phillips Capital Management Lookout Mountain, Tennessee $137M AUM 15.57% 1-Year Est. Return

Syntax Research's Q2 2025 Portfolio in Review

As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.

  • Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
  • Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
  • Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
  • Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
  • Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
  • Syntax Research opened 7 new positions and closed 12 in Q2 2025.
  • Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.

Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.